Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016.
Arthritis care & research
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
Nature reviews. Rheumatology
Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.
Annals of the rheumatic diseases